1. Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab. Issue 21 (16th September 2022) Authors: Nindra, Udit; Shahnam, Adel; Stevens, Samuel; Pal, Abhijit; Nagrial, Adnan; Lee, Jenny; Yip, Po Yee; Adam, Tamiem; Boyer, Michael; Kao, Steven; Bray, Victoria Journal: Thoracic cancer Issue: Volume 13:Issue 21(2022) Page Start: 3058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗